Tag : Darzalex

Latest News

Study Investigating Darzalex®▼ (daratumumab) Shows Improved Depth of Response and Progression-Free Survival in Patients with Newly Diagnosed Multiple Myeloma Who are Eligible for a Transplant

Newsemia
BEERSE, Belgium–(BUSINESS WIRE)–The Janssen Pharmaceutical Companies of Johnson & Johnson announced today results from the Phase 3 CASSIOPEIA (MMY3006, NCT02541383) study, an Intergroupe Francophone du...
Latest News

Darzalex ®▼ (daratumumab) utilizzato in regimi terapeutici di combinazione mostra risultati positivi per pazienti con mieloma multiplo di nuova diagnosi e recidivo

Newsemia
BEERSE, Belgio–(BUSINESS WIRE)–Le società farmaceutiche Janssen di Johnson & Johnson hanno oggi annunciato i risultati a lungo termine dello studio clinico di fase III ALCYONE,...
Latest News

Darzalex ®▼ (daratumumab) Combination Regimens Show Positive Results for Newly Diagnosed and Relapsed Patients with Multiple Myeloma

Newsemia
BEERSE, Belgium–(BUSINESS WIRE)–The Janssen Pharmaceutical Companies of Johnson & Johnson announced today long-term results from the Phase 3 ALCYONE study showing that the addition of...
Latest News

Janssen’s Darzalex receives positive CHMP opinion for treating multiple myeloma patients

Newsemia
The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy